drugset / Trial / NCT04291599

Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid

NCT04291599

RandomizedParallel-groupOpen-labelSupportive care

Summary

This will be a phase 2, single-center, unblinded randomized controlled pilot trial of two arms comparing opioid-sparing analgesia to the current Boston Children's Hospital institutional practice which has been reported to predominantly include administration of opioids as a first-line analgesic to pediatric patients who present to the emergency department with a diagnosis of acute pancreatitis (AP). This is a pilot trial for which many outcomes have not previously been studied in the pediatric AP population. The focus of this investigation will be to investigate the magnitude and variability of effect sizes for designing a future multi-center, double-blinded randomized controlled trial.

Timeline

Start
2022-03-15
Primary completion
2025-07-24
Completion
2025-07-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified Intravenous
Comparator Hydromorphone Other / unclassified
Comparator Morphine Other / unclassified 0.025 mg/kg

Indications